AeroLeads people directory · profile
Steve Kye Email & Phone Number
Vice President Clinical Development
at
Pathos
1 work email found
@pathos.com
5 phones found area 650, 626, and 714
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Vice President Clinical Development
Location
Los Angeles, California, United States
Company size
Who is Steve Kye? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Steve Kye is listed as Vice President Clinical Development at Pathos, a company with 88 employees, based in Los Angeles, California, United States. AeroLeads shows a work email signal at pathos.com, phone signal with area code 650, 626, 714, and a matched LinkedIn profile for Steve Kye.
Steve Kye previously worked as Vice President, Clinical Development - Myelofibrosis and MDS at Karyopharm Therapeutics Inc. and Head of Hematology and Cytokine Oncology Programs, Clinical Development at Xencor. Steve Kye holds Bachelor'S Degree, Microbiology And Molecular Genetics from Ucla.
Company email context
Email format at Pathos
This section adds company-level context without repeating Steve Kye's masked contact details.
{first}.{last}@pathos.com
89% confidence
AeroLeads found 1 current-domain work email signal for Steve Kye. Compare company email patterns before reaching out.
Profile bio
About Steve Kye
Strategic thinking clinical development and medical affairs leader (MD and MPH) with excellent verbal and written communication skills. Recognized for the ability to drive product development from concept to approval with success. Detail-oriented self-starter who can prioritize multiple tasks to meet strict deadlines. Strong understanding of Good Clinical Practices (GCP), Good Laboratory Practice (GLP), ICH guidelines, FDA CFRs, clinical research ethics, HIPAA and patient privacy regulations, EU Directive, and other local regulations. Experienced in case report form and protocol development for IDE clinical studies to be used in PMA (Premarket Approval) applications and 510k submission to FDA. Well-versed in clinical study designs, regulatory submission requirements, hospital workflows, and clinical procedures. Record of success in every position held with awards and publications.Other areas of expertise include lung cancer prevention, infectious diseases, healthcare management, and strategic planning, research and development, molecular diagnostic testing, clinical laboratory procedures, and database planning and management.
Listed skills include Clinical Research, Clinical Trials, Cancer, Infectious Diseases, and 43 others.
Current workplace
Steve Kye's current company
Company context helps verify the profile and gives searchers a useful next step.
Pathos
15 roles
Steve Kye work experience
A career timeline built from the work history available for this profile.
Vice President, Clinical Development - Myelofibrosis And Mds
Current
Mar 2023 - Present
Head Of Hematology And Cytokine Oncology Programs, Clinical Development
- Lead for heme malignancy (lymphoma and myeloid malignancies) and cytokine solid tumor clinical developments- Successfully led IND submission and IND approval: XmAb306/RO7310729; IL-15 bispecific antibody in Lymphoma and XmAb-662; IL-12 bispecific antibody in Advanced Solid Tumor.
Jul 2022 - Mar 2023
Executive Medical Director, Clinical Development
Oct 2021 - Mar 2023
Head Of Hematology, Clinical Development
Apr 2022 - Jul 2022
Venetoclax Mds Global Development Lead (Gdl)
- Successfully led FDA Breakthrough Therapy Designation (BTD) for Venetoclax in Higher-Risk MDS (July 2021)
Jun 2020 - Oct 2021
Senior Medical Director, Hematology/Oncology Global Development
- Hematology/Oncology - Venetoclax Clinical Development in MDS and AML
Sep 2018 - Oct 2021
Medical Director, Clinical Development
- Responsible for overseeing the direction, planning, execution, data collection activities, and interpretation of key clinical trials Clinical Development Lead for:
- ACE-CL-006; Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia
- ACE-CL-208; A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy
Oct 2017 - Sep 2018
Medical Director, Medical Affairs & Clinical Development
- Led medical affairs and clinical development teams for immune-oncology (I-O) products (Opdivo® and Yervoy®) and I-O strategic alliance with Bristol-Myers Squibb (BMS) worldwide and local medical affairs/commercial teams
- Developed and executed medical affairs strategies with strict adherence to local regulations
- Foster strong relationships with academic societies, hospitals and medical professions (KOLs)
- Presented relevant clinical trials data at various conferences and physician group meetings
- Medical and compliance review of materials for symposiums, scientific exchange meetings (SEMs), etc.
- Addressed medical unmet needs and developed advisory board meetings (ABM/ad board) and SEMs
May 2016 - Oct 2017
Medical Director / Vp Of Business Development
- Developed clinical development strategies for the US-FDA 510(k) approvals for a breast cancer test kit (GenesWell-BCT)
- Scientifically reviewed new business opportunities and managed licensing-in/out activities for business development
- Researched industry trends and identified new business lead opportunities for mergers & acquisitions (M&A) activities
- Made corporate presentations at various investor relations (IR) and venture capitalist events.
Nov 2015 - May 2016
Principal Medical Advisor, Medical Affairs And Clinical Development
- Lead MSL activities including new KOL developments and maintained relationships with KOLs in nephology, pulmonary, and internal medicine through seminars and by co-developing investigator initiated research (ISRs).
- Developed RMP strategy and strengthened PV program which included more sophisticated safety reporting system (created safety database and web-based PV reporting system for HCPs)
- Managed medical information (MI) activities for HCP’s medical information queries and medical claims
- Directed clinical research QA activities (internal audits) in accordance with local GCP and ICH guidelines
- Developed a business plan for the new companion diagnostics business unit and received corporate approval
- Main therapeutic areas: cardiovascular/gastrointestinal (GI) diseases/oncology/infectious diseases/nephrology.
Dec 2014 - Nov 2015
Senior Clinical Scientist
- Successfully managed a multicenter clinical trial which later received EU regulatory approval (CE-IVD)- Experienced in FDA IDE clinical studies for PMA applications and 510(k) submissions- Developed clinical study plans and protocols for clinical validations based on reviewed scientific publications- Developed key opinion leaders (KOLs) and made.
May 2013 - Dec 2014
Clinical Study/Research Project Manager
- Successfully managed a multicenter NIH-sponsored phase 2b lung cancer chemoprevention trial
Nov 2011 - Apr 2013
Postdoctoral Fellow
Discovered an unusual protein aggregation pattern in HIV infected cells and isolated it to the HIV-1 gagIdentified potential drug targets and key compounds for treating enteroviral infections using proteomicsCollaborated with many key principal investigators on a novel antiviral discovery projectMade scientific presentations at key scientific conferences.
Jun 2009 - Oct 2011
Clinical Research Manager, Lung Cancer Chemoprevention
Managed two NIH-sponsored multicenter phase 2 lung cancer chemoprevention clinical trialsSupervised clinical trial activities including study subject recruitment and patient educationsMonitored clinical study records and reviewed/interpreted clinical trial data using SAS and SPSSCreated and managed clinical sample bank databaseAuthored conference posters.
Apr 2008 - May 2009
4 education records
Steve Kye education
Bachelor'S Degree, Microbiology And Molecular Genetics
Ucla
Md, Medicine
Seoul National University
Mph, Health Policy And Management
Emory University
Postdoctoral Fellowship, Infectious Diseases
David Geffen School Of Medicine At Ucla
FAQ
Frequently asked questions about Steve Kye
Quick answers generated from the profile data available on this page.
What company does Steve Kye work for?
Steve Kye works for Pathos.
What is Steve Kye's role at Pathos?
Steve Kye is listed as Vice President Clinical Development at Pathos.
What is Steve Kye's email address?
AeroLeads has found 1 work email signal at @pathos.com for Steve Kye at Pathos.
What is Steve Kye's phone number?
AeroLeads has found 5 phone signal(s) with area code 650, 626, 714 for Steve Kye at Pathos.
Where is Steve Kye based?
Steve Kye is based in Los Angeles, California, United States while working with Pathos.
What companies has Steve Kye worked for?
Steve Kye has worked for Pathos, Karyopharm Therapeutics Inc., Xencor, Abbvie, and Acerta Pharma B.V. (A Member Of The Astrazeneca Group).
How can I contact Steve Kye?
You can use AeroLeads to view verified contact signals for Steve Kye at Pathos, including work email, phone, and LinkedIn data when available.
What schools did Steve Kye attend?
Steve Kye holds Bachelor'S Degree, Microbiology And Molecular Genetics from Ucla.
What skills is Steve Kye known for?
Steve Kye is listed with skills including Clinical Research, Clinical Trials, Cancer, Infectious Diseases, Oncology, Immunology, Healthcare, and Biotechnology.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial